Learning Objectives • Describe applicable results of important histology-specific clinical trials and put into clinical context • Identify investigational therapeutic regimens that would be alternatives to standard of care approaches • Evaluate current clinical practice approaches and applications to each specific patient and suggest alternative radiology, pathology, and clinical practices
Accreditation and Credit Statement Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Mayo Clinic College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DISCLOSURE Conference Directors / Planning Committee No Relevant Financial Relationship(s) Thomas M. Habermann, M.D. Rebecca L. King, M.D. Thomas E. Witzig, M.D. Off Label/Investigational Usage Any off-label or investigational use of a drug of device should be announced to others if discussed.
The following are off-label or investigational use and may come up during discussion: Pharmacylics, Jansen Ibrutinib Gilead Sciences Idelalisib Celgene Lenalidomide Seattle Genetics Brentuximab vedotin Novartis, Kite CAR T-cells Merck Pembrulizumab Bristol-Meyers Squibb Novolumab Novartis Everolimus Millenium/Takeda Alisertib AbbVie/Genentech/Roche Venetoclax AbbVie/Genetech/Roche Ibrutinib Takeda Bortezomib
Recommend
More recommend